These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 31177454)
1. Oncolytic Activity of the Vaccine Strain of Type 3 Poliovirus on the Model of Rat Glioma C6 Cells. Sosnovtseva AO; Zheltukhin AO; Lipatova AV; Chumakov PM; Chekhonin VP Bull Exp Biol Med; 2019 May; 167(1):111-115. PubMed ID: 31177454 [TBL] [Abstract][Full Text] [Related]
2. Sensitivity of C6 Glioma Cells Carrying the Human Poliovirus Receptor to Oncolytic Polioviruses. Sosnovtseva AO; Lipatova AV; Grinenko NF; Baklaushev VP; Chumakov PM; Chekhonin VP Bull Exp Biol Med; 2016 Oct; 161(6):821-825. PubMed ID: 27783287 [TBL] [Abstract][Full Text] [Related]
3. Oncolytic Virotherapy for the Treatment of Malignant Glioma. Foreman PM; Friedman GK; Cassady KA; Markert JM Neurotherapeutics; 2017 Apr; 14(2):333-344. PubMed ID: 28265902 [TBL] [Abstract][Full Text] [Related]
4. [Oncolytic properties of some orthopoxviruses, adenoviruses and parvoviruses in human glioma cells]. Razumov IA; Sviatchenko VA; Protopopova EV; Kochneva GV; Kiselev NN; Gubanova NV; Shilov AG; Mordvinov VA; Netesov SV; Chumakov PM; Loktev VB Vestn Ross Akad Med Nauk; 2013; (12):4-8. PubMed ID: 24741936 [TBL] [Abstract][Full Text] [Related]
5. The alpha/beta interferon response controls tissue tropism and pathogenicity of poliovirus. Ida-Hosonuma M; Iwasaki T; Yoshikawa T; Nagata N; Sato Y; Sata T; Yoneyama M; Fujita T; Taya C; Yonekawa H; Koike S J Virol; 2005 Apr; 79(7):4460-9. PubMed ID: 15767446 [TBL] [Abstract][Full Text] [Related]
6. Tumour-specific triple-regulated oncolytic herpes virus to target glioma. Delwar ZM; Liu G; Kuo Y; Lee C; Bu L; Rennie PS; Jia WW Oncotarget; 2016 May; 7(19):28658-69. PubMed ID: 27070093 [TBL] [Abstract][Full Text] [Related]
7. Interferon Beta and Interferon Alpha 2a Differentially Protect Head and Neck Cancer Cells from Vesicular Stomatitis Virus-Induced Oncolysis. Westcott MM; Liu J; Rajani K; D'Agostino R; Lyles DS; Porosnicu M J Virol; 2015 Aug; 89(15):7944-54. PubMed ID: 25995245 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-Attenuated Clone of Virulent Semliki Forest Virus Overcomes Antiviral Type I Interferon in Resistant Mouse CT-2A Glioma. Martikainen M; Niittykoski M; von und zu Fraunberg M; Immonen A; Koponen S; van Geenen M; Vähä-Koskela M; Ylösmäki E; Jääskeläinen JE; Saksela K; Hinkkanen A J Virol; 2015 Oct; 89(20):10637-47. PubMed ID: 26269187 [TBL] [Abstract][Full Text] [Related]
9. Immune Checkpoint Blockade, Immunogenic Chemotherapy or IFN-α Blockade Boost the Local and Abscopal Effects of Oncolytic Virotherapy. Fend L; Yamazaki T; Remy C; Fahrner C; Gantzer M; Nourtier V; Préville X; Quéméneur E; Kepp O; Adam J; Marabelle A; Pitt JM; Kroemer G; Zitvogel L Cancer Res; 2017 Aug; 77(15):4146-4157. PubMed ID: 28536278 [TBL] [Abstract][Full Text] [Related]
11. Targeting of interferon-beta to produce a specific, multi-mechanistic oncolytic vaccinia virus. Kirn DH; Wang Y; Le Boeuf F; Bell J; Thorne SH PLoS Med; 2007 Dec; 4(12):e353. PubMed ID: 18162040 [TBL] [Abstract][Full Text] [Related]